logo

JBCHEPHARM vs RPGLIFE: Stock Comparison

JBCHEPHARM vs RPG LIFE SCIENCESUpdated 16 Jul 26, 4:08 PM ISTNSE & company filings

JBCHEPHARM shows a lower P/E, a higher dividend yield and lower leverage, while RPG LIFE SCIENCES shows a higher ROE, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

JBCHEPHARM leads 5; RPGLIFE leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

JBCHEPHARMRPGLIFE

Valuation lens

What price are you paying?

Market CapContext only
₹0 Cr
₹4,621 Cr
P/E RatioJBCHEPHARM has the lower reading
54.59x ✓
55.81x
P/B RatioRPGLIFE has the lower reading
9.31x
7.63x ✓
EPSRPGLIFE has the higher reading
₹6.31
₹18.6 ✓
Book ValueContext only
₹259.05
₹366.03
Dividend YieldJBCHEPHARM has the higher reading
0.88% ✓
0.86%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
JBCHEPHARM has a lower P/E
54.59x vs 55.81x
P/B Ratio
RPGLIFE has a lower P/B
7.63x vs 9.31x
EPS
RPGLIFE has higher earnings per share
₹18.6 vs ₹6.31
Dividend Yield
JBCHEPHARM has a higher dividend yield
0.88% vs 0.86%
Revenue Growth (TTM YoY)
RPGLIFE has faster revenue growth
23.6% vs -4.8%
EPS Growth (TTM YoY)
JBCHEPHARM has faster EPS growth
-31% vs -74.5%
ROE
RPGLIFE has a higher ROE
19.02% vs 16.7%
ROCE
RPGLIFE has a higher ROCE
22.63% vs 17.05%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricJBCHEPHARMRPGLIFE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricJBCHEPHARMRPGLIFE
Live Price₹2,408.9₹2,780.2
Day Change-3.87%-0.61%
Volume47.79 L9,175
52-Week High₹2,525.5₹3,127.8
52-Week Low₹1,675₹1,733
Distance from 52W High-4.62%-11.11%

Valuation

MetricJBCHEPHARMRPGLIFE
Market Cap₹0 Cr₹4,621 Cr
P/E Ratio54.59x55.81x
P/B Ratio9.31x7.63x
EPS₹6.31₹18.6
Book Value₹259.05₹366.03
Dividend Yield0.88%0.86%

Growth

MetricJBCHEPHARMRPGLIFE
Revenue Growth (TTM YoY)-4.8%23.6%
EPS Growth (TTM YoY)-31%-74.5%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricJBCHEPHARMRPGLIFE
ROE16.7%19.02%
ROCE17.05%22.63%
Net Margin17.1%29.25%
Operating Margin23.33%21.92%
Debt to Equity0x0.03x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricJBCHEPHARMRPGLIFE
Promoter Holding48.8%▲ 48.8 pp72.95%
FII Holding16.33%▲ 1.45 pp0.87%▼ 0.08 pp
DII Holding21.38%▼ 1.98 pp9.93%▲ 1.26 pp
Public Holding13.48%▼ 0.74 pp16.25%▼ 1.17 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: JBCHEPHARM and RPG LIFE SCIENCES.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.